Ondansetron Biogaran

Ondansetron, the active ingredient in Ondansetron Biogaran, is a 5‑HT₃ receptor antagonist presented as a medication for oral or injectable use to prevent nausea and vomiting. It is commonly employed in patients receiving chemotherapy, radiation therapy, or undergoing surgery.

GNH USA supplies Ondansetron Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

Ondansetron is used to control nausea and vomiting associated with several therapeutic pathways.

- Chemotherapy‑induced nausea and vomiting: reduces acute and delayed episodes in cancer patients receiving emetogenic chemotherapy. - Radiation‑induced nausea and vomiting: prevents nausea during and after radiotherapy to the abdomen or pelvis. - Postoperative nausea and vomiting: decreases incidence of nausea and vomiting after surgical procedures.

Ondansetron may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Fatigue: feeling of tiredness. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - QT interval prolongation: may lead to cardiac arrhythmias. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Serotonin syndrome: agitation, hyperreflexia, fever (rare when combined with serotonergic agents).

When prescribing ondansetron, clinicians should consider several safety measures. - Cardiac monitoring: assess baseline ECG in patients with known QT prolongation. - Electrolyte balance: correct hypokalemia or hypomagnesemia before use. - Drug interactions: review concomitant medications that affect cardiac conduction. - Pregnancy: use only if potential benefit justifies risk; discuss with obstetrician. - Breastfeeding: limited data; weigh benefits against possible infant exposure. - Store at room temperature: keep below 25 °C, protect from moisture and light in original packaging.

Ondansetron can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Amiodarone: combined use may markedly increase QT prolongation risk. - Certain antiarrhythmics (e.g., sotalol, quinidine): additive effect on cardiac repolarization. - Tricyclic antidepressants (e.g., amitriptyline): may enhance QT interval changes.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole, fluconazole): can raise ondansetron plasma levels. - Antiemetics with serotonergic activity (e.g., granisetron): potential for serotonin syndrome. - CYP3A4 inhibitors (e.g., erythromycin): may increase exposure, monitor for side effects.